MétaCan
Menu
Back to cohort
Record W4412737070 · doi:10.1186/s12888-025-07030-9

Optimizing treatment for depression in primary care using psychotherapy versus antidepressant medication in a low-resource setting: protocol for the OptimizeD randomized controlled trial

2025· article· en· W4412737070 on OpenAlexaff
Julia R Pozuelo, Anuja Lahiri, Arvind Kushwah, Mimansa Khanduri, Akanksha Shukla, Azaz Khan, G. Sruthi, Varun Shende, Yashika Parashar, Yashwant K. Mehra, Anant Bhan, Ronald C. Kessler, Daisy R. Singla, John A. Naslund, Karmel W. Choi, Pim Cuijpers, Robert J. DeRubeis, Mohammad M. Herzallah, Chunling Lu, Jordan W. Smoller, Tyler J. VanderWeele, Abhijit R. Rozatkar, Tamonud Modak, Michelle Melwyn Joel, Debasis Biswas, Shubham Atal, Umay Kulsum, Steven D. Hollon, Vikram Patel

Bibliographic record

VenueBMC Psychiatry · 2025
Typearticle
Languageen
FieldMedicine
TopicTreatment of Major Depression
Canadian institutionsLunenfeld-Tanenbaum Research InstituteUniversity of TorontoCentre for Addiction and Mental Health
FundersNational Institute of Mental Health
KeywordsAntidepressantRandomized controlled trialProtocol (science)Depression (economics)Primary carePsychotherapistPsychiatryMedicinePsychologyAnxietyAlternative medicineInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Psychotherapy and antidepressant medications are first-line treatments for depression, and they both have significant treatment effects on average. However, treatment response varies widely across patients, and neither approach is universally effective. Identifying the most effective treatment for each patient is critical everywhere, but particularly in low-resource settings where access to mental health care is limited. The Optimizing Depression (OptimizeD) trial aims to explore whether different patients respond differently to behavioral activation therapy versus antidepressant medication and if providing each patient with their optimal treatment improves outcomes in primary care. METHODS: We plan to randomize 1,500 patients with moderate to severe depression (defined as a Patient Health Questionnaire [PHQ-9] score ≥ 10) from primary healthcare settings in Bhopal, India, with equal allocation either to a culturally adapted behavioral activation therapy delivered by trained counselors (Healthy Activity Program) or to antidepressant medication (fluoxetine). Treatment will last 3 months, with remission (defined as PHQ-9 score < 5) at 3 months as the primary endpoint. Using machine learning, we will attempt to develop a precision treatment rule that leverages baseline clinical, psychological, cognitive, socioeconomic, and biological data to predict which treatment is most likely to achieve remission for each patient. Cost-effectiveness analysis will then assess whether the added costs of optimizing treatment are justified by improvements in remission, recovery, and cost savings at the health system and societal levels. Secondary and exploratory objectives include assessing the effectiveness of optimization in a range of secondary outcomes, evaluating treatment mechanisms, and exploring whether incorporating genetic and biological markers as predictors improves treatment optimization. DISCUSSION: The OptimizeD trial will evaluate whether baseline information collected in routine care can inform optimal depression treatment selection and identify predictors of nonresponse to facilitate timely specialist referrals. Findings have the potential to enhance personalized depression care in primary health systems, particularly in low-resource settings, with broader implications for global public health. TRIAL REGISTRATION: ClinicalTrials.gov (NCT05944926; registered July 2, 2023) and Clinical Trials Registry India (CTRI/2024/01/061932; registered January 29, 2024).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.051
metaresearch head score (Gemma)0.052
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.080
Threshold uncertainty score0.269

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0510.052
Meta-epidemiology (narrow)0.0070.004
Meta-epidemiology (broad)0.0120.009
Bibliometrics0.0030.005
Science and technology studies0.0040.005
Scholarly communication0.0060.004
Open science0.0040.003
Research integrity0.0070.011
Insufficient payload (model declined to judge)0.0800.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.370
Teacher spread0.339 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBMC PsychiatrySame topicTreatment of Major DepressionFrench-language works237,207